C09996: A Congestive Heart Failure Management ProgramNovelty:
This program uses patient variables to determine optimal treatment plans for patients with congestive heart failure.
Value Proposition:
Congestive heart failure (CHF) is a final common pathway for patients with a variety of cardiovascular diseases and is one of the most frequent admitting diseases in the United States. However, considerable treatment variation across the country and studies indicate that most patients are not receiving appropriate therapy. In addition, low-cost interventions such as phone calls to ensure that medications are taken and that patients are weighed daily significantly decrease hospital readmission rates. The purpose of this program is to improve the care quality, cost effectiveness, and satisfaction of patients with CHF. Advantages include:
• Focuses on higher-level variables like patient history, treatments, and outcomes
• Includes a centralized system to provide optimal treatment plans
• Comes with a significant amount of data within the system
Technical Details:
Johns Hopkins researchers have invented a diagnostic and therapeutic program for CHF using a computer application. The first component is an evaluation of the pathophysiology, etiology, and activity of the disease, associated co-morbidity as well as social, educational, and financial information, which may be relevant to outcomes. The second component is the physician input in terms of therapeutic intervention including medications, telephone calls, nursing intervention, physical therapy, sub-acute care, and special outpatient clinic facilities. The third component is the quality measurement systems which will be used to measure outcomes.
Looking for Partners:
To develop and commercialize the technology as a program to improve the diagnosis and treatment of CHF.
Stage of Development:
Patient data validated
Data Availability:
Under CDA/NDA
Publications/Associated Cases:
Not available at this time
